“ERT’s solutions continued to break new ground within the past year, benefiting its customers around the globe and we’re excited to have them featured on our top companies’ list.”
PHILADELPHIA (PRWEB) December 21, 2015
ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced it has been named one of the 2015 20 Most Promising Data Integration Solution Providers by CIO Review. The annual list of companies is selected by a panel of experts and members of CIO Review’s editorial board to recognize and promote technology entrepreneurship.
The selection is based on ERT’s Insights Cloud - a new paradigm in clinical technology that provides sponsors and CROs with comprehensive insight into the risk and performance of clinical trials. Insights Cloud includes a technology-agnostic data hub with a proprietary integration framework that enables rapid deployment and near real time data exchange with leading data capture systems including IVR / IRT, EDC, and ePRO. This harmonized data is processed in the Insights Cloud analytics engine to derive aggregate status information, risk indicators and performance metrics, ultimately delivering decision-ready analytics that help to optimize the clinical research process.
“ERT has been on our radar for some time now, for stirring a revolution in the clinical development landscape and we are happy to showcase them due to their continuing excellence in delivering top-notch technology-driven solutions,” said Harvi Sachar, Publisher and Founder, CIO Review. “ERT’s solutions continued to break new ground within the past year, benefiting its customers around the globe and we’re excited to have them featured on our top companies’ list.”
“We are very proud to be included in this year’s CIO Review Top 20 List,” said James Corrigan, President and CEO of ERT. “ERT Insights Cloud is changing the way pharmaceutical companies and CROs access and analyze critical data across their various clinical trial data streams – we are pleased that so many new and existing customers are benefitting from the significant efficiency gains delivered by this innovative solution.”
For additional information on the ERT Insights Cloud visit https://www.ert.com/insights-cloud.
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products.
ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., and in Germany, Japan, Switzerland and the U.K.